BRD4 and myocardial infarction: Furthermore, the histone acetylation reader BRD4 undergoes genome-wide stimulus-dependent redistribution in cardiac fibroblasts, suggesting that the BRD4 inhibitor JQ1 could be used for the treatment of HF and myocardial infarction in the future [142].